Arizona State Retirement System increased its stake in HealthEquity, Inc. (NASDAQ:HQY) by 0.9% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 23,097 shares of the company’s stock after buying an additional 200 shares during the period. Arizona State Retirement System’s holdings in HealthEquity were worth $1,151,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Neuburgh Advisers LLC boosted its position in HealthEquity by 0.4% in the first quarter. Neuburgh Advisers LLC now owns 31,968 shares of the company’s stock valued at $1,357,000 after buying an additional 112 shares during the last quarter. Glen Harbor Capital Management LLC boosted its position in HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock valued at $1,866,000 after buying an additional 154 shares during the last quarter. Elkfork Partners LLC boosted its position in HealthEquity by 0.4% in the first quarter. Elkfork Partners LLC now owns 55,944 shares of the company’s stock valued at $2,375,000 after buying an additional 196 shares during the last quarter. State of Alaska Department of Revenue boosted its position in HealthEquity by 4.3% in the first quarter. State of Alaska Department of Revenue now owns 4,850 shares of the company’s stock valued at $205,000 after buying an additional 200 shares during the last quarter. Finally, Louisiana State Employees Retirement System boosted its position in HealthEquity by 1.1% in the second quarter. Louisiana State Employees Retirement System now owns 18,100 shares of the company’s stock valued at $902,000 after buying an additional 200 shares during the last quarter. 91.86% of the stock is owned by hedge funds and other institutional investors.

Shares of HealthEquity, Inc. (NASDAQ:HQY) opened at 40.60 on Tuesday. The stock has a market capitalization of $2.43 billion, a P/E ratio of 76.32 and a beta of 1.73. HealthEquity, Inc. has a 12-month low of $30.34 and a 12-month high of $54.95. The stock has a 50 day moving average price of $46.96 and a 200 day moving average price of $45.88.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, June 6th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The company had revenue of $55.40 million for the quarter, compared to the consensus estimate of $54.77 million. During the same quarter in the previous year, the firm posted $0.15 EPS. The business’s revenue was up 25.9% compared to the same quarter last year. On average, equities analysts anticipate that HealthEquity, Inc. will post $0.58 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/29/arizona-state-retirement-system-has-1-15-million-stake-in-healthequity-inc-hqy.html.

HQY has been the subject of a number of recent analyst reports. Cantor Fitzgerald lifted their price target on HealthEquity from $50.00 to $55.00 and gave the stock an “overweight” rating in a report on Wednesday, June 7th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $61.00 price target (up from $57.00) on shares of HealthEquity in a report on Monday, June 12th. BidaskClub downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price target for the company in a report on Wednesday, July 12th. Finally, Chardan Capital lifted their price target on HealthEquity from $53.00 to $57.00 and gave the stock a “buy” rating in a report on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the stock. HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $50.22.

In related news, major shareholder Berkley Capital, Llc sold 248,351 shares of the company’s stock in a transaction dated Tuesday, June 13th. The shares were sold at an average price of $52.80, for a total value of $13,112,932.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Ashley Dreier sold 10,000 shares of the company’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $47.81, for a total transaction of $478,100.00. Following the completion of the sale, the vice president now directly owns 15,652 shares in the company, valued at approximately $748,322.12. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,458,821 shares of company stock worth $126,120,793. Insiders own 19.00% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.